Factors associated with the use of COVID-19 vaccine during pregnancy: evidence from a multicenter Brazilian cross-sectional study

OBJECTIVES: We aimed to understand factors that influence the decision-making process of Brazilian pregnant women to receive a COVID-19 vaccine during pregnancy. METHODS: We conducted a cross-sectional survey between August and December 2023 in two Brazilian cities. Pregnant women aged ≥18 years or emancipated attending antenatal care at public facilities were invited to participate. Those eligible completed a structured questionnaire developed and validated by Johns Hopkins University, covering sociodemographic characteristics, COVID-19 vaccination history, attitudes, beliefs, and reasons for vaccine acceptance or refusal. Participants were grouped as vaccinated during any pregnancy or missed vaccination during any pregnancy. Data were analyzed using descriptive statistics, chi-square tests, and t-tests (p < 0.05). Ethical approval was obtained, and data were securely managed in REDCap with quality control procedures to ensure accuracy and consistency. RESULTS: Among 402 pregnant women surveyed, 109 received a COVID-19 vaccine dose during pregnancy, while 279 missed vaccination during pregnancy. Number of doses varied by group; women vaccinated during pregnancy were more likely to have higher number of doses. There were similar overall dose counts across pregnancy trimesters. Women vaccinated during pregnancy reported greater confidence in vaccine safety and effectiveness for themselves and their fetus and were less likely to express negative beliefs about vaccination. Missing vaccination during pregnancy was associated with preference for natural immunity and concerns about vaccine unnaturalness. CONCLUSION: A low proportion of pregnant women received COVID-19 vaccines during pregnancy. Having doubts about vaccine safety, efficacy, and COVID-19 severity were associated with missing vaccination during pregnancy. Addressing these factors is crucial for enhancing public health policies and improving the adherence of pregnant women to vaccination.

Authors

Institutions

Publication Details

Journal
Vaccine
Published
2026-04-01
DOI
https://doi.org/10.1016/j.vaccine.2026.128549
Primary Topic
COVID-19 Impact on Reproduction
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Factors associated with the use of COVID-19 vaccine during pregnancy: evidence from a multicenter Brazilian cross-sectional study

Vanessa Brizuela, Rupali J. Limaye, Ruth A. Karron, Grace Belayneh et al.
Vaccine
COVID-19 Impact on Reproduction
article

Factors associated with the use of COVID-19 vaccine during pregnancy: evidence from a multicenter Brazilian cross-sectional study

Vanessa Brizuela, Rupali J. Limaye, Ruth A. Karron, Grace Belayneh, Ana Arthur, Jessica L. Schue, Sami L. Gottlieb, Berhaun Fesshaye, Ricardo Porto Tedesco, Ibukun Abejirinde, Bruna Maudonnet, Renato T. Souza, Jacinta P. Matias, Jose G. Cecatti, Prachi Singh, Carla Silveira, Maria Elisa Silveira de Souza, Maria L. Costa, Mateus Tosetto, Emily Miller
article en

Abstract

OBJECTIVES: We aimed to understand factors that influence the decision-making process of Brazilian pregnant women to receive a COVID-19 vaccine during pregnancy. METHODS: We conducted a cross-sectional survey between August and December 2023 in two Brazilian cities. Pregnant women aged ≥18 years or emancipated attending antenatal care at public facilities were invited to participate. Those eligible completed a structured questionnaire developed and validated by Johns Hopkins University, covering sociodemographic characteristics, COVID-19 vaccination history, attitudes, beliefs, and reasons for vaccine acceptance or refusal. Participants were grouped as vaccinated during any pregnancy or missed vaccination during any pregnancy. Data were analyzed using descriptive statistics, chi-square tests, and t-tests (p < 0.05). Ethical approval was obtained, and data were securely managed in REDCap with quality control procedures to ensure accuracy and consistency. RESULTS: Among 402 pregnant women surveyed, 109 received a COVID-19 vaccine dose during pregnancy, while 279 missed vaccination during pregnancy. Number of doses varied by group; women vaccinated during pregnancy were more likely to have higher number of doses. There were similar overall dose counts across pregnancy trimesters. Women vaccinated during pregnancy reported greater confidence in vaccine safety and effectiveness for themselves and their fetus and were less likely to express negative beliefs about vaccination. Missing vaccination during pregnancy was associated with preference for natural immunity and concerns about vaccine unnaturalness. CONCLUSION: A low proportion of pregnant women received COVID-19 vaccines during pregnancy. Having doubts about vaccine safety, efficacy, and COVID-19 severity were associated with missing vaccination during pregnancy. Addressing these factors is crucial for enhancing public health policies and improving the adherence of pregnant women to vaccination.

Vaccine
Johns Hopkins University (US), Universidade Estadual de Campinas (UNICAMP) (BR), World Health Organization (CH), Faculdade de Medicina de Jundiaí (BR)
Bill and Melinda Gates Foundation, World Health Organization, Fundação de Amparo à Pesquisa do Estado de São Paulo
Good health and well-being
Openalex Percentile: Top 20%
COVID-19 Impact on Reproduction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.